For an 18-year-old male who had his lamotrigine dose increased from 25 mg to 50 mg, what are the next best steps to assess the rash for Stevens‑Johnson syndrome and when should referral to the emergency department be recommended?

Immediate Action Required: Stop Lamotrigine and Evaluate for Stevens-Johnson Syndrome

You must see this patient urgently today—ideally within hours—and immediately discontinue lamotrigine until SJS/TEN is ruled out. Lamotrigine is a well-established cause of SJS/TEN, particularly in young patients, and anticonvulsants are among the most common culprits in this age group 1. The timing (rash developing days after dose escalation) and presentation (itching progressing to rash on extremities) are concerning for a drug hypersensitivity reaction that could evolve into life-threatening SJS/TEN.

Critical Assessment Parameters

Immediate Clinical Evaluation

When you see this patient, assess for the following red flags that distinguish benign rash from SJS/TEN:

Mucosal involvement (most critical early feature):

• Examine mouth, eyes, and genitalia for erosions, ulcerations, or hemorrhagic crusting
• Ocular inflammation may precede skin findings 1

Skin characteristics:

• Purple/dusky red macules or flat atypical target lesions (not raised urticarial lesions)
• Positive Nikolsky sign: gentle lateral pressure causes epidermis to separate/slide
• Flaccid bullae or areas of epidermal detachment
• Confluent erythema with skin tenderness to touch
• Calculate body surface area (BSA) of detachment: <10% = SJS, 10-30% = overlap, >30% = TEN 1

Systemic symptoms:

• Fever (often precedes rash by days)
• Malaise, upper respiratory symptoms
• Cutaneous pain is a prominent early feature that should heighten suspicion 1

Key Distinguishing Features

This is likely SJS/TEN if:

• Mucosal involvement present (eyes, mouth, genitals)
• Flat dusky lesions rather than raised bumps
• Skin is painful and tender
• Positive Nikolsky sign
• Systemic symptoms (fever, malaise)

Less concerning for SJS/TEN if:

• No mucosal involvement
• Raised urticarial lesions only
• No systemic symptoms
• Skin not tender or painful

When to Send to Emergency Department

Immediate ED referral is indicated if ANY of the following:

• Any mucosal involvement (oral, ocular, or genital erosions)
• Epidermal detachment >10% BSA 1
• Positive Nikolsky sign
• Fever with rash
• Facial edema or angioedema
• Confluent erythema with skin tenderness
• Systemic symptoms (difficulty breathing, hypotension, altered mental status)
• Any uncertainty about diagnosis—when in doubt, refer 2, 1

The UK guidelines emphasize that patients with >10% BSA epidermal loss should be admitted without delay to a burn center or ICU with experience treating SJS/TEN 2. For young people, transfer to a center with pediatric/young adult experience in managing SJS/TEN is recommended 1.

Initial Management Steps

If SJS/TEN is Suspected (Before or During ED Transfer):

1. Discontinue lamotrigine immediately—this is the single most important intervention and decreases mortality 1

2. Document thoroughly:

   • Photograph the rash (type and extent of lesions) 2
   • Record vital signs including oxygen saturation
   • Calculate BSA involvement
   • Document all medications with start dates

3. Do NOT rechallenge with lamotrigine if SJS/TEN is confirmed—this is not a benign rash scenario 3

If Benign Rash (No Red Flags):

Even if the rash appears benign:

• Still discontinue lamotrigine until you can examine the patient
• Schedule urgent in-person evaluation (same day if possible)
• Instruct patient to go to ED immediately if they develop fever, mouth sores, eye irritation, or worsening rash
• Do not restart lamotrigine without direct visualization and assessment

Critical Timing Considerations

The latency period for lamotrigine-induced SJS/TEN is typically 5-28 days after drug initiation 2, though most cases occur within the first 8 weeks 4. Your patient's dose was increased recently, and rash developed "over the past few days," placing him squarely in the high-risk window. The risk is particularly elevated when lamotrigine is combined with valproic acid (which slows lamotrigine metabolism) 5, 6, so verify if he's on any other medications.

Common Pitfalls to Avoid

1. Don't wait to see if the rash improves—SJS/TEN can progress rapidly from benign-appearing rash to life-threatening condition within 24-48 hours

2. Don't assume it's "just a drug rash"—18-year-old males on lamotrigine are in a high-risk demographic for SJS/TEN 1

3. Don't restart lamotrigine if there's any doubt—mortality from SJS/TEN ranges from 0% (pure SJS) to 8.5% (TEN) in young people 1, and rechallenge after true SJS is contraindicated

4. Don't delay referral if mucosal involvement is present—this requires specialized multidisciplinary care including ophthalmology 2, 1

The evidence is unequivocal: lamotrigine must be stopped immediately, the patient must be seen urgently, and any signs of SJS/TEN warrant immediate ED referral. Early drug discontinuation is the only intervention proven to reduce mortality 1.